The regulatory landscape of precision oncology laboratory medicine in the United States – Perspective on the past 5 years and considerations for future regulation
Open Access
- 30 May 2020
- journal article
- research article
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 21, e00172
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A somatic reference standard for cancer genome sequencingScientific Reports, 2016
- Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCRBMJ Open, 2016
- Validation of a Next-Generation–Sequencing Cancer Panel for Use in the Clinical LaboratoryArchives of Pathology & Laboratory Medicine, 2014
- Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencingJournal of Clinical Pathology, 2014
- Comparison of Targeted Next‐Generation Sequencing (NGS) and Real‐Time PCR in the Detection of EGFR, KRAS, and BRAF Mutations on Formalin‐Fixed, Paraffin‐Embedded Tumor Material of Non‐Small Cell Lung Carcinoma—Superiority of NGSGenes, Chromosomes and Cancer, 2013
- Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for VemurafenibPLOS ONE, 2013
- College of American Pathologists Proposal for the Oversight of Laboratory-Developed TestsArchives of Pathology & Laboratory Medicine, 2011
- Regulatory Approval Pathways for Molecular Diagnostic Technology2011
- Institute of Medicine, Rewarding provider performance (aligning incentives in medicare), Washington, D.C., National Academies Press, 2007, 248 pp., ISBN-13: 978-0-309-10216-2; ISBN-10: 0-309-10216-2The International Journal of Health Planning and Management, 2008
- Medical Errors Arising from Outsourcing Laboratory and Radiology ServicesThe American Journal of Medicine, 2007